Table 3.
Correlation between clozapine dosage (mg day−1 kg−1) and plasma clozapine concentrations (Spearman correlations)
All samples | Male (n = 116) | Female (n = 77) | <40 years (n = 82) | ≥40 years old (n = 111) | Male smokers (n = 50) | Male non-smokers (n = 66) | |
---|---|---|---|---|---|---|---|
CLZ (ng ml−1) | r = 0.264** | 0.352** | 0.120 | 0.365** | 0.124 | 0.371** | 0.268* |
NCLZ (ng ml−1) | r = 0.420** | 0.485** | 0.310** | 0.449** | 0.358** | 0.505** | 0.374** |
Sum (ng ml−1) | r = 0.322** | 0.410** | 0.177 | 0.400** | 0.203** | 0.418** | 0.327** |
NCLZ/CLZ | r = 0.151* | 0.132 | 0.267** | 0.061 | 0.214* | 0.058 | 0.148 |
Correlation is significant at the 0.01 level (two-tailed).
Correlation is significant at the 0.05 level. CLZ, Clozapine; NCLZ, norclozapine.